James Drage
Direktor/Vorstandsmitglied bei Fe Pharmaceuticals (Canada), Inc.
Ursprung des Netzwerks ersten Grades von James Drage
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Fe Pharmaceuticals, Inc.
 Fe Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fe Pharmaceuticals, Inc. is a company based in San Diego, CA. Fe Pharmaceuticals, Inc. was founded by Bruce Holbein and is currently led by CEO Michael J. Weickert.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Fe Pharmaceuticals (Canada), Inc.
 Fe Pharmaceuticals (Canada), Inc. Pharmaceuticals: MajorHealth Technology Fe Pharmaceuticals (Canada), Inc. operates as a research institution. It offers indication & treatment challenge, technical innovation and market services. The company was founded by William M. Cheliak and Bruce Holbein and is headquartered in Halifax, Canada.
6
| Private Company | Pharmaceuticals: Major | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von James Drage
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Avicena Group, Inc.
 Avicena Group, Inc. Pharmaceuticals: MajorHealth Technology Avicena Group, Inc. develops pharmaceuticals and skin care products. It focuses on developing products based on its proprietary understanding of the regulation of cellular energy processes. The company's core technologies have broad applications in both pharmaceuticals and dermaceuticals. Avicena Group was founded by Rima Kaddurah-Daouk and M. Flint Beal in 1989 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Arizona | College/University | Doctorate Degree | |
Greenfire Bio LLC
 Greenfire Bio LLC BiotechnologyHealth Technology Greenfire Bio LLC is a private company that focuses on developing clinical agents for cancer treatment. Greenfire Bio is based in Frisco, TX. The company's flagship product, grn-300, is a first-in-class sik inhibitor for ovarian cancer patients. The company was founded by Ajit S. Gill and he has been the CEO since incorporation. | Biotechnology | Chief Operating Officer | |
Ohm Oncology, Inc.
 Ohm Oncology, Inc. Pharmaceuticals: MajorHealth Technology Ohm Oncology, Inc. is a drug development company. It treats drug resistant neoplasms and cancers with novel multi-mechanism compounds. The company was founded by Vamsi Maddipatla and Ram S. Upadhayaya and is headquartered in Austin, TX. | Pharmaceuticals: Major | Chief Operating Officer | |
| University of Wisconsin | College/University | Doctorate Degree | |
Somatogen, Inc.
 Somatogen, Inc. BiotechnologyHealth Technology Somatogen, Inc. develops specialty oxygen therapeutics. It is engaged in the research, clinical development and commercialization of genetically engineered recombinant human hemoglobin-based products. The company is located in Boulder, CO. | Biotechnology | Corporate Officer/Principal | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Sales & Marketing | |
| CORIUM INTERNATIONAL INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Corporate Officer/Principal | |
| Evergreen State College | College/University | Undergraduate Degree | |
| Oberlin College | College/University | Undergraduate Degree | |
Northwest Technology Ventures
 Northwest Technology Ventures Investment ManagersFinance Northwest Technology Ventures (Northwest Tech Ventures) is a venture capital firm founded in 2001. The firm is headquartered in Portland, Oregon. | Investment Managers | Private Equity Investor | |
Pancreatic Cancer Action Network, Inc.
 Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Pancreatic Cancer Action Network, Inc. engages in the research, clinical initiatives, patient services, and advocacy for pancreatic cancer. The company was founded in 1999 and is headquartered in Manhattan Beach, CA. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
| RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| California Institute for Regenerative Medicine | General Government | Director/Board Member | |
| CHEMOCENTRYX, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Harvard T.H. Chan School of Public Health | College/University | Graduate Degree | |
| AFFYMAX, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of Toronto | College/University | Doctorate Degree | |
Pacylex Pharmaceuticals, Inc.
 Pacylex Pharmaceuticals, Inc. Hospital/Nursing ManagementHealth Services Pacylex Pharmaceuticals, Inc. offers medicine solutions for cancers. The company is based in Edmonton, Canada. The CEO of the Canadian company is Michael J. Weickert. | Hospital/Nursing Management | Chief Executive Officer |
Statistik
International
| Vereinigte Staaten | 27 |
| Kanada | 3 |
| Frankreich | 2 |
Sektoral
| Health Technology | 18 |
| Consumer Services | 8 |
| Health Services | 4 |
| Finance | 2 |
| Government | 2 |
Operativ
| Director/Board Member | 12 |
| Corporate Officer/Principal | 8 |
| Chief Tech/Sci/R&D Officer | 6 |
| Chief Executive Officer | 5 |
| Chief Operating Officer | 5 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- James Drage
- Unternehmensverbindungen
